Cytomegalovirus Viremia and Death After Hematopoietic Cell Transplantation: More Complex Than "To Have and Have Not"?
- PMID: 31179483
- PMCID: PMC7346759
- DOI: 10.1093/cid/ciz492
Cytomegalovirus Viremia and Death After Hematopoietic Cell Transplantation: More Complex Than "To Have and Have Not"?
Comment on
-
A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation.Clin Infect Dis. 2020 Apr 10;70(8):1525-1533. doi: 10.1093/cid/ciz490. Clin Infect Dis. 2020. PMID: 31179485 Free PMC article. Clinical Trial.
References
-
- Meyers JD, Reed EC, Shepp DH, et al. . Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med 1988; 318:70–5. - PubMed
-
- Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 1993; 118:173–8. - PubMed
-
- Duke ER, Gilbert PB, Stevens-Ayers TL, et al. . Viral kinetic correlates of cytomegalovirus disease and death after hematopoietic cell transplant. Biol Blood Marrow Transplant 2018; 24: S20–4.
